TY - JOUR
T1 - Revisiting the role of IRF3 in inflammation and immunity by conditional and specifically targeted gene ablation in mice
AU - Yanai, Hideyuki
AU - Chiba, Shiho
AU - Hangai, Sho
AU - Kometani, Kohei
AU - Inoue, Asuka
AU - Kimura, Yoshitaka
AU - Abe, Takaya
AU - Kiyonari, Hiroshi
AU - Nishio, Junko
AU - Taguchi-Atarashi, Naoko
AU - Mizushima, Yu
AU - Negishi, Hideo
AU - Grosschedl, Rudolf
AU - Taniguchi, Tadatsugu
N1 - Funding Information:
ACKNOWLEDGMENTS. We thank M. Reth (Max Planck Institute of Immunobiology and Epigenetics) and T. Kurosaki (RIKEN Center for Integrative Medical Sciences) for providing the Mb1-Cre mice. We also thank M. Sugahara, M. Yasui, and C.-Y. Chang for their technical assistance. This work was supported in part by Grant-In-Aid for Scientific Research (S) 15638461 from the Ministry of Education, Culture, Sports, Science of Japan; Grant AMED-PRIME 1005352 from the Japan Agency for Medical Research and Development, the Uehara Memorial Foundation, and the Princess Takamatsu Cancer Research Fund. The Department of Molecular Immunology is supported by BONAC Corporation and Kyowa Hakko Kirin Co., Ltd.
Funding Information:
RIKEN BioResource Research Center through the National BioResource Project of the Ministry of Education, Culture, Sports, and Technology of Japan. All animal experiments were done in accordance with guidelines of The University of Tokyo and RIKEN Kobe Branch.
Funding Information:
We thank M. Reth (Max Planck Institute of Immunobiology and Epigenetics) and T. Kurosaki (RIKEN Center for Integrative Medical Sciences) for providing the Mb1-Cre mice. We also thank M. Sugahara, M. Yasui, and C.-Y. Chang for their technical assistance. This work was supported in part by Grant-In-Aid for Scientific Research (S) 15638461 from the Ministry of Education, Culture, Sports, Science of Japan; Grant AMED-PRIME 1005352 from the Japan Agency for Medical Research and Development, the Uehara Memorial Foundation, and the Princess Takamatsu Cancer Research Fund. The Department of Molecular Immunology is supported by BONAC Corporation and Kyowa Hakko Kirin Co., Ltd.
Publisher Copyright:
© 2018 National Academy of Sciences. All rights reserved.
PY - 2018/5/15
Y1 - 2018/5/15
N2 - IFN regulatory factor 3 (IRF3) is a transcription regulator of cellular responses in many cell types that is known to be essential for innate immunity. To confirm IRF3’s broad role in immunity and to more fully discern its role in various cellular subsets, we engineered Irf3-floxed mice to allow for the cell type-specific ablation of Irf3. Analysis of these mice confirmed the general requirement of IRF3 for the evocation of type I IFN responses in vitro and in vivo. Furthermore, immune cell ontogeny and frequencies of immune cell types were unaffected when Irf3 was selectively inactivated in either T cells or B cells in the mice. Interestingly, in a model of lipopolysaccharide-induced septic shock, selective Irf3 deficiency in myeloid cells led to reduced levels of type I IFN in the sera and increased survival of these mice, indicating the myeloid-specific, pathogenic role of the Toll-like receptor 4–IRF3 type I IFN axis in this model of sepsis. Thus, Irf3-floxed mice can serve as useful tool for further exploring the cell type-specific functions of this transcription factor.
AB - IFN regulatory factor 3 (IRF3) is a transcription regulator of cellular responses in many cell types that is known to be essential for innate immunity. To confirm IRF3’s broad role in immunity and to more fully discern its role in various cellular subsets, we engineered Irf3-floxed mice to allow for the cell type-specific ablation of Irf3. Analysis of these mice confirmed the general requirement of IRF3 for the evocation of type I IFN responses in vitro and in vivo. Furthermore, immune cell ontogeny and frequencies of immune cell types were unaffected when Irf3 was selectively inactivated in either T cells or B cells in the mice. Interestingly, in a model of lipopolysaccharide-induced septic shock, selective Irf3 deficiency in myeloid cells led to reduced levels of type I IFN in the sera and increased survival of these mice, indicating the myeloid-specific, pathogenic role of the Toll-like receptor 4–IRF3 type I IFN axis in this model of sepsis. Thus, Irf3-floxed mice can serve as useful tool for further exploring the cell type-specific functions of this transcription factor.
KW - Bcl2l12
KW - Infection
KW - Inflammation
KW - Interferon
KW - IRF3
UR - http://www.scopus.com/inward/record.url?scp=85046961443&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046961443&partnerID=8YFLogxK
U2 - 10.1073/pnas.1803936115
DO - 10.1073/pnas.1803936115
M3 - Article
C2 - 29712834
AN - SCOPUS:85046961443
SN - 0027-8424
VL - 115
SP - 5253
EP - 5258
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 20
ER -